Lisa E Gralinski Selected Research

Lisa E Gralinski Research Topics

Disease

23	Infections 01/2024 - 01/2007
13	COVID-19 02/2022 - 01/2020
8	Inflammation (Inflammations) 02/2022 - 09/2016
8	Virus Diseases (Viral Diseases) 01/2020 - 04/2013
2	Tertiary Lymphoid Structures 02/2022 - 01/2022
2	Chronic Disease (Chronic Diseases) 02/2022 - 01/2022
2	Lung Diseases (Lung Disease) 01/2021 - 12/2020
2	Acute Lung Injury 11/2020 - 08/2013
2	Weight Loss (Weight Reduction) 05/2020 - 01/2020
2	Coronavirus Infections 01/2020 - 10/2018
2	Human Influenza (Influenza) 01/2019 - 05/2014
2	Severe Acute Respiratory Syndrome 01/2018 - 03/2014
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 11/2020
1	Mycoses (Diseases, Fungus) 10/2018
1	Ebola Hemorrhagic Fever 01/2017
1	RNA Virus Infections 04/2014
1	Eosinophilia 03/2014
1	Wounds and Injuries (Trauma) 08/2013
1	Herpes Zoster 09/2009
1	Neoplasms (Cancer) 08/2002

Drug/Important Bio-Agent (IBA)

13	VaccinesIBA 11/2021 - 03/2014
11	Proteins (Proteins, Gene)FDA Link 10/2021 - 01/2007
7	Antiviral Agents (Antivirals)IBA 01/2024 - 04/2013
5	CytokinesIBA 01/2021 - 04/2013
4	AntibodiesIBA 11/2020 - 01/2020
4	RNA (Ribonucleic Acid)IBA 01/2020 - 01/2014
3	InterferonsIBA 01/2024 - 01/2014
3	molnupiravirIBA 02/2022 - 01/2021
3	ChemokinesIBA 01/2021 - 01/2007
3	Monoclonal AntibodiesIBA 01/2020 - 12/2015
2	CollagenIBA 02/2022 - 01/2022
2	nintedanibIBA 02/2022 - 01/2022
2	Angiotensin-Converting Enzyme 2IBA 12/2020 - 01/2020
2	COV2-2130IBA 05/2020 - 01/2020
2	Transcription Factors (Transcription Factor)IBA 04/2013 - 08/2002
1	Broadly Neutralizing AntibodiesIBA 02/2022
1	EpitopesIBA 02/2022
1	AnticoagulantsIBA 10/2021
1	Biomarkers (Surrogate Marker)IBA 10/2021
1	Interferon Type IIBA 01/2021
1	LipidsIBA 01/2021
1	Immunoglobulin G (IgG)IBA 11/2020
1	Surface-Active Agents (Surfactants)IBA 11/2020
1	Neutralizing AntibodiesIBA 10/2020
1	NucleoproteinsIBA 10/2020
1	Immunoglobulin A (IgA)IBA 10/2020
1	Viral RNAIBA 10/2020
1	LuciferasesIBA 01/2020
1	Blocking AntibodiesIBA 01/2020
1	Peptide Hydrolases (Proteases)FDA Link 01/2020
1	TrypsinIBA 01/2020
1	COV2-2196IBA 01/2020
1	ErbB Receptors (EGF Receptor)IBA 01/2019
1	Complement System Proteins (Complement)IBA 10/2018
1	ProTidesIBA 01/2017
1	remdesivirIBA 01/2017
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2016
1	Protein Phosphatase 1IBA 09/2016
1	Protein Isoforms (Isoforms)IBA 06/2014
1	Histones (Histone)IBA 05/2014
1	Attenuated VaccinesIBA 04/2014
1	Glycoproteins (Glycoprotein)IBA 03/2014
1	Fibrinolysin FDA Link 08/2013
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 08/2013
1	GlucocorticoidsIBA 04/2013
1	Phosphotransferases (Kinase)IBA 04/2013
1	Hormones (Hormone)IBA 04/2013
1	Karyopherins (Importin)IBA 04/2013
1	Claudin-5IBA 09/2009
1	Tight Junction ProteinsIBA 09/2009
1	OccludinIBA 09/2009

Therapy/Procedure

3	Therapeutics 10/2021 - 01/2017
1	Intranasal Administration 10/2020
1	Artificial Respiration (Mechanical Ventilation) 09/2020